ARA-290
ARA-290
Research Use Only and not for human consumption. Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance.
Couldn't load pickup availability
Description
ARA-290
ARA-290 (also known as Cibinetide) is a synthetic 11-amino acid peptide derived from erythropoietin (EPO). Unlike standard EPO, it is non-erythropoietic, meaning it does not stimulate red blood cell production. Instead, it selectively targets the Innate Repair Receptor (IRR) to activate pathways for tissue protection and anti-inflammation
- Nerve Damage
It is primarily studied for treating chronic neuropathic pain, Nerve Repair and inflammation, particularly in diabetes and sarcoidosis - Anti-Inflammatory Effects:
It works by down-regulating inflammatory cytokines and modulating microglial activation in the central nervous system. - Metabolic Support:
Phase 2 clinical trials have shown improvements in HbA1c levels and lipid profiles in patients with type 2 diabetes. - Tissue Protection:
It helps prevent cell death and promotes healing in tissues damaged by hypoxia or metabolic stress
